Clinical Trials Directory

Trials / Completed

CompletedNCT05833477

Tracing Changed Production of Red Blood Cells

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In competitive sport, it is illegal to manipulate erythropoiesis. Manipulated erythropoiesis can indirectly be identified by atypical fluctuations in key haematological variables. However, this method also has limitations and as it is known that some athletes still manipulate erythropoiesis it is necessary to develop new and more sensitive detection methods. The primary purpose of the study is to examine the importance of altered erythropoiesis for surface and intracellular erythrocyte proteins, the number of immature reticulocytes, and for the haematological characteristics of the erythrocyte, such as volume, haemoglobin concentration and concentration of glycosylated haemoglobin, to assess whether these can be used to identify changed erythropoiesis. Furthermore, the aim is to examine whether these parameters are affected by freezer storage of erythrocytes.

Conditions

Interventions

TypeNameDescription
DRUGRecombinant human erythropoietinRecombinant human erythropoietin treatment three times per week for three weeks

Timeline

Start date
2022-10-28
Primary completion
2022-12-16
Completion
2022-12-16
First posted
2023-04-27
Last updated
2023-04-27

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05833477. Inclusion in this directory is not an endorsement.